Cardiovascular disease (CVD) remains the leading cause of mortality for women, and only a small percentage of women have optimally managed risk factors. One of the strongest risk factors for CVD is an increased lipid level. Many women seek primary care from obstetrician–gynecologists who often identify and provide initial management of dyslipidemia in these women. Thus, it is imperative that obstetrician–gynecologists become familiar with the identification and treatment of women with dyslipidemia to minimize their future risk of CVD. This monograph provides a brief primer on the epidemiology, pathophysiology, diagnosis, and management of dyslipidemia in women, as it pertains to CVD risk.
This document provides a clinically oriented overview of a condition or issue that affects women's health. It was developed by the American College of Obstetricians and Gynecologists' Editorial Board for Clinical Updates in Women's Health Care in collaboration with Bridgette A. Christopher, MD, PhD, and Neha J. Pagidipati, MD, MPH.
This information is designed as an educational resource to aid clinicians in providing obstetric and gynecologic care, and use of this information is voluntary. This information should not be considered as inclusive of all proper treatments or methods of care or as a statement of the standard of care. It is not intended to substitute for the independent professional judgment of the treating clinician. Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The College reviews its publications regularly; however, its publications may not reflect the most recent evidence. Any updates to this document can be found on www.clinicalupdates.org or by calling the College's Resource Center.
While the College makes every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. The College does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither the College nor its officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.
The full-text version of this document is available at www.clinicalupdates.org
Volume XVIII, Number 2 March 2019
Copyright March 2019 by American College of Obstetricians and Gynecologists. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, posted on the Internet, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior permission from the publisher.
Requests for authorization to make photocopies should be directed to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400.
American College of Obstetricians and Gynecologists 409 12th Street SW, PO Box 96920 Washington, DC 20090-6920
Christopher BA, Pagidipati NJ. Evaluation and management of lipid disorders: summary. Clinical Updates in Women's Health Care. American College of Obstetricians and Gynecologists. Obstet Gynecol 2019;133:609.